Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Agilent’s eArray online design tool supports gene study on autism spectrum disorders (ASD)

Agilent Technologies Europe : 21 January, 2008  (New Product)
Agilent Technologies has announced results from a study that establishes a relationship between autism spectrum disorders (ASD) and extra or missing genes on a section of chromosome 16 used Agilent microarrays to detect these microdeletions and microduplications.
The study represents the largest, most complete genome scan for ASDs to date. Completed in October 2007, the study used three independent data sources. One analysis was conducted by the Autism Consortium, a collaboration of 14 leading universities and medical centres including Children's Hospital Boston. Another was completed by deCODE Genetics, in Iceland. The third was performed at Children's Hospital Boston using clinical samples from its own patients.

Researchers screened samples from 936 children from Children's Hospital Boston using Agilent comparative genomic hybridisation (CGH) microarrays. Microarrays are glass slides containing thousands of DNA ‘features’ that enable scientists to examine large numbers of genes simultaneously. CGH microarrays are designed specifically to detect chromosomal additions and deletions.

The Children's Hospital team used Agilent's online design tool, eArray, to develop custom microarrays for the study. 'The ability to reliably find extremely small missing or extra pieces of DNA has evolved just within the past six to eight months,' noted co-author Yiping Shen, PhD, director of research and development at the Children's Genetic Diagnostic Laboratory.

Using Agilent microarrays, Children's Hospital researchers found five instances of the deletion among 512 patients referred for developmental delay or suspected ASDs. In addition, the Children's Hospital team identified four patients with a duplication rather than a deletion.

'Our findings certainly have the potential for use in evaluating children for development delay and autism,' says Bai-Lin Wu, PhD, director of the Children's Hospital Genetic Diagnostic Laboratory, leader of the Children's team on the study and a senior author of the paper.

'Genomics researchers demand tools that give them the freedom to design their own types of experiments, deliver reproducible results and spend fewer dollars per experiment,' said Yvonne Linney, PhD, vice president and general manager, Genomics, at Agilent. 'This work is a good example of how far the technology has come.'

The study ‘Association between Microdeletion and Microduplication at 16p11.2 and Autism’, was published January 9 in The New England Journal of Medicine online,
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   Â© 2012
Netgains Logo